Latest News of PRTA
Prothena Corporation plc (PTRA): Positioning Among Top Debt-Free Stocks
Prothena Corporation plc (NASDAQ:PRTA) is among the best debt-free stocks to buy due to its focus on developing treatments for neurodegenerative diseases. With strong financials and strategic collabor...
While shareholders of Prothena (NASDAQ:PRTA) are in the black over 5 years, those who bought a week ago aren't so fortunate
Prothena Corporation's stock price fell by 13% in a week, but long-term returns have been strong with a 146% gain over five years. Revenue growth has been impressive at 40% per year, indicating potent...
Here's Why We're Not Too Worried About Prothena's (NASDAQ:PRTA) Cash Burn Situation
Despite the risk of cash burn, Prothena (NASDAQ:PRTA) seems to manage its finances well. With a 3.4-year cash runway, revenue growth, and potential breakeven in 4 years, shareholders need not worry....